Condition

Multidrug Resistant Tuberculosis clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Multidrug Resistant Tuberculosis clinical trials that are recruiting, at sites in 3 countries (most in Niger (1), China (1), France (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Multidrug Resistant Tuberculosis clinical trials

StudyPhaseWhereStatusRegistered
Comparing the effectiveness of tedizolid and linezolid for treating tuberculosis Phase 2 Paris Recruiting Sep 9, 2022
New all-oral treatment for rifampicin-resistant tuberculosis Phase 3 Guiyang, Guizhou and 4 other locations Recruiting Oct 18, 2021
High-dose treatment for recurrent tuberculosis Phase 3 Niamey Recruiting Feb 7, 2020

All recruiting trials (3)

Related topics

TuberculosisPulmonary Tuberculosis

Quick answers

How many Multidrug Resistant Tuberculosis clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Niger (1 trial), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.